Format

Send to

Choose Destination
Am J Sports Med. 2019 Nov;47(13):3238-3246. doi: 10.1177/0363546519877181. Epub 2019 Oct 11.

Positive Effect of Platelet-Rich Plasma on Pain in Plantar Fasciitis: A Double-Blind Multicenter Randomized Controlled Trial.

Author information

1
Department of Orthopaedics, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.
2
Department of Methodology and Statistics, Tilburg University, Tilburg, the Netherlands.
3
Department of Medical and Clinical Psychology, Centre of Research on Psychological and Somatic Disorders, Tilburg University, Tilburg, the Netherlands.
4
Department of Orthopaedics, Ikazia Ziekenhuis, Rotterdam, the Netherlands.
5
Department of Orthopaedics, Diaconessenhuis Leiden, the Netherlands.
6
Department of Orthopaedics, Elisabeth Ziekenhuis Tilburg, the Netherlands.

Abstract

BACKGROUND:

When nonoperative treatment for chronic plantar fasciitis fails, often a corticosteroid injection is given. Corticosteroid injection gives temporary pain reduction but no healing. Platelet-rich plasma (PRP) has proven to be a safe therapeutic option in the treatment of tendon, muscle, bone, and cartilage injuries.

PURPOSE:

To determine the effectiveness of PRP as compared with corticosteroid injections for chronic plantar fasciitis.

STUDY DESIGN:

Randomized controlled trial; Level of evidence, 1.

METHODS:

Patients with chronic plantar fasciitis were allocated to have steroid injection or PRP. The primary outcome measure was the Foot Function Index (FFI) Pain score. Secondary outcome measures were function, as scored by the FFI Activity, FFI Disability, and American Orthopaedic Foot & Ankle Society, and quality of life, as scored with the short version of the World Health Organization Quality of Life (WHOQOL-BREF). All outcomes were measured at baseline and at 4, 12, and 26 weeks and 1 year after the procedure.

RESULTS:

Of the 115 patients, 63 were allocated to the PRP group, of which 46 (73%) completed the study, and 52 were allocated to the control group (corticosteroid injection), of which 36 (69%) completed the study. In the control group, FFI Pain scores decreased quickly and then remained stable during follow-up. In the PRP group, FFI Pain reduction was more modest but reached a lower point after 12 months than the control group. After adjusting for baseline differences, the PRP group showed significantly lower pain scores at the 1-year follow-up than the control group (mean difference, 14.4; 95% CI, 3.2-25.6). The number of patients with at least 25% improvement (FFI Pain score) between baseline and 12-month follow-up differed significantly between the groups. Of the 46 patients in the PRP group, 39 (84.4%) improved at least 25%, while only 20 (55.6%) of the 36 in the control group showed such an improvement (P = .003). The PRP group showed significantly lower FFI Disability scores than the control group (mean difference, 12.0; 95% CI, 2.3-21.6).

CONCLUSION:

Treatment of patients with chronic plantar fasciitis with PRP seems to reduce pain and increase function more as compared with the effect of corticosteroid injection.

REGISTRATION:

NCT00758641 (ClinicalTrials.gov identifier).

KEYWORDS:

corticosteroids; function; pain; plantar fasciitis; platelet-rich plasma

PMID:
31603721
DOI:
10.1177/0363546519877181

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center